socioeconom statu cancer surviv surviv data cancer leukemia group calgb protocol patient lung cancer multipl myeloma gastric cancer pancreat cancer breast cancer hodgkin diseas differ surviv rate attribut cancer initi perform statu age protocol-specif prognost indic addit predict valu socioeconom statu se race white non-whit signific predictor surviv time incom educ peopl annual incom year year educ level grade school surviv time incom educ surviv differ sever diseas initi present se small signific impact cancer surviv prognost variabl cancer patient treatment program educ treatment complianc initi diagnosi treatment se surviv independ prognost variabl data base clinic trial group accur test effect new therapi 